Publications

Jaan Biotherapeutics, Inc. Financial Conflict of Interest (FCOI) Policy Effective: August 1, 2025 Introduction. The purpose of this policy is to ensure that research funded by the National Institutes of Health (NIH) is designed, conducted, and reported…

.

Healing the heart by manipulating microRNAsJaan Biotherapeutics is developing first-in-class therapies that repair damaged heart muscle and treat cardiovascular diseases by reactivating an endogenous regeneration process that has been shut down in the...